A byproduct produced when tryptophan is metabolized by gut bacteria could become a natural obesity treatment, a new study in rats found. It opens the door to a natural, side-effect-free alternative to GLP-1 drugs like Ozempic.
A byproduct produced when tryptophan is metabolized by gut bacteria could become a natural obesity treatment, a new study in rats found. It opens the door to a natural, side-effect-free alternative to GLP-1 drugs like Ozempic.
